Profile
Nick DeLong is the founder of Evolved Capital, Inc. He previously worked as the Head of Business Development at Tris Pharma, Inc. and as the Vice President of Corporate Development at iBio, Inc. He holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Rutgers University- Newark.
Former positions of Nick DeLong
| Companies | Position | End |
|---|---|---|
| IBIO, INC. | Corporate Officer/Principal | 2024-05-31 |
Evolved Capital, Inc.
Evolved Capital, Inc. Packaged SoftwareTechnology Services Develops web-based tool | Founder | - |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Corporate Officer/Principal | - |
Training of Nick DeLong
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Rutgers University- Newark
Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolved Capital, Inc.
Evolved Capital, Inc. Packaged SoftwareTechnology Services Develops web-based tool | Technology Services |
- Stock Market
- Insiders
- Nick DeLong
















